Bio-Techne Corporation (TECH) Stock Grade

About Bio-Techne Corporation's fundamentals

Bio-Techne Corporation is a biotechnology company with an $8.1 billion market capitalization that generated 5.2% year-over-year revenue growth, though profitability remains modest with a net margin of 6.0%. The company trades at a P/E ratio of 110.4, significantly above typical market averages, while generating a return on equity of just 3.8%—indicating that shareholder capital is not being deployed particularly efficiently. With a dividend yield of 0.6%, the company returns minimal cash to investors, instead retaining earnings for operations and growth initiatives.